(Q61939586)

English

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

scientific article published on 26 July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Jacques Van Dongen

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Jesús San Miguel

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

15

object named as

A Orfao

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M W van den Beemd

9

object named as

M W van den Beemd

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

author name string

G Gaipa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E G van Lochem

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E R van Wering

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Porwit-MacDonald

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T Faria

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Bjorklund

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Biondi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Baars

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B Vidriales

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Parreira

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

BIOMED-I

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1185-1192

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11480560%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402150

0 references

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes: testing of a new fixation-permeabilization solution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402150

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61939586&oldid=2115028617"